Skip to main content

Reborna Biosciences

Fujisawa, Japan

Reborna Biosciences is a biotechnology firm offering research and development of RNA-targeting small molecule drugs for genetic diseases.

$5.3M raised
Jun 2025
Venture - Series Unknown

Top Investors

ICMG VenturesMitsubishi UFJ CapitalNissay CapitalTakedaUntroD Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Reborna Biosciences

How much funding has Reborna Biosciences raised?
Reborna Biosciences has raised $5.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2025.
Who are Reborna Biosciences's investors?
Reborna Biosciences's investors include ICMG Ventures, Mitsubishi UFJ Capital, Nissay Capital, Takeda, UntroD Capital.
Where is Reborna Biosciences headquartered?
Reborna Biosciences is headquartered in Fujisawa, Japan.
What does Reborna Biosciences do?
Reborna Biosciences is a biotechnology firm offering research and development of RNA-targeting small molecule drugs for genetic diseases.
What stage is Reborna Biosciences at?
Reborna Biosciences is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Reborna Biosciences — Funding & Investors." VCBacked, June 25, 2025, https://www.vcbacked.co/company/reborna-biosciences. Accessed June 4, 2026.
APA
VCBacked. (2025). Reborna Biosciences — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/reborna-biosciences
Wikipedia (cite web)
{{cite web |title=Reborna Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/reborna-biosciences |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .